The National Oncologic PET Registry (NOPR): design and analysis plan.
about
Opening up the optical imaging window using nano-luciferin.Impact on Patient Management of [18F]-Fluorodeoxyglucose-Positron Emission Tomography (PET) Used for Cancer Diagnosis: Analysis of Data From the National Oncologic PET Registry.Ethical issues in using data from quality management programs.Prospective study of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma.Using patient management as a surrogate for patient health outcomes in diagnostic test evaluationImpact of dedicated brain PET on intended patient management in participants of the national oncologic PET Registry.PET/CT without capacity limitations: a Danish experience from a European perspective.Imaging and cancer: a review.PET Imaging of Prostate Cancer Using C-Acetate.Should positron emission tomography/computed tomography be the first rather than the last test performed in the assessment of cancer?A review of imaging agent development.Combined PET/MRI: from Status Quo to Status Go. Summary Report of the Fifth International Workshop on PET/MR Imaging; February 15-19, 2016; Tübingen, Germany.Geographic and sociodemographic disparities in PET use by Medicare beneficiaries with cancer.Intended versus inferred care after PET performed for initial staging in the National Oncologic PET Registry.The impact of positron emission tomography (PET) on expected management during cancer treatment: findings of the National Oncologic PET Registry.Combined PET/MR: The Real Work Has Just Started. Summary Report of the Third International Workshop on PET/MR Imaging; February 17-21, 2014, Tübingen, Germany
P2860
Q30596619-C632F7CA-D681-4A2F-B1FB-BCA1C2931599Q31113917-EC8309F3-6A66-4EFE-A685-3DAF48E77161Q33430032-C1DD82E4-0A54-4EE1-BB30-9379E4E880B1Q33670824-645F77C1-4F2F-4EDC-B3EF-6BE3554ED922Q34158661-229CF782-3D56-45E0-B186-669B8B1F76B7Q34500953-843142D0-6830-4EC9-8759-F24A39B99675Q34940350-ADEF2DC2-FE75-41E4-B035-93F331D2F2FCQ34977050-FF8A2448-8568-45EA-9DD5-FA4A57D1D947Q35288176-F43473F8-66A7-4834-B657-103CEEEAD9B8Q36286485-A79A1DD0-5A46-4C4B-A3D8-2F6771D77BF5Q37214528-5E9922BF-3930-46E0-AF60-CADA42848477Q37230617-F3F09D3E-C11A-4A28-8CB6-19143EFB5A45Q37316598-C867907B-3321-48E5-95A0-D51D5D43AE61Q37365689-286C89C5-C5CC-4ECA-9E96-7598917CE4CBQ40027009-03BD48A3-4991-40A6-B283-EA67D43F1A36Q42566769-F768B675-831A-4FC0-8295-934C60DBD593
P2860
The National Oncologic PET Registry (NOPR): design and analysis plan.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
The National Oncologic PET Registry (NOPR): design and analysis plan.
@en
The National Oncologic PET Registry
@nl
type
label
The National Oncologic PET Registry (NOPR): design and analysis plan.
@en
The National Oncologic PET Registry
@nl
prefLabel
The National Oncologic PET Registry (NOPR): design and analysis plan.
@en
The National Oncologic PET Registry
@nl
P2093
P1476
The National Oncologic PET Registry (NOPR): design and analysis plan.
@en
P2093
Anthony F Shields
Barry A Siegel
Bruce E Hillner
Lucy Hanna
R Edward Coleman
Sharon Hartson Stine
P304
P356
10.2967/JNUMED.107.043687
P407
P577
2007-10-17T00:00:00Z